DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Brian Wu PhD. MD Candidate, Keck School of Medicine, Los Angeles, USA; Chief Editor: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand, February 2016.
Ascher syndrome is characterised by persistent swelling of the lip and eyelids, and sometimes by nontoxic thyroid enlargement.
It was first described in 1920 by Dr. Ascher, an ophthalmologist in Prague. It is also sometimes called blepharochalasis and double lip.
Ascher syndrome is rare. It appears to have no prevalence by sex, age, sex or geographical area.
The exact cause of Ascher syndrome is unknown. If acquired, swelling of the lips and eyelids is usually due to trauma. If congenital, it stems from some developmental anomaly.
The three salient characteristics of Ascher syndrome include:
Staging of blepharochalasis is as follows:
Associated signs and symptoms of this condition include:
Angioedema causing eyelid or lip oedema is not persistent, and last hours to a few days.
Persistent eyelid oedema is sometimes a feature of phymatous rosacea.
Treatment for Ascher syndrome can include surgery:
With surgical treatment, prognosis is good and functional and aesthetic improvement can be achieved.
See the DermNet NZ bookstore.
© 2021 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.